BiomX (PHGE) Long-Term Deferred Tax (2019 - 2022)
BiomX (PHGE) posted Long-Term Deferred Tax of $24.5 million for Q4 2022, down 6.48% sequentially from $26.2 million in Q4 2021, and down 6.48% YoY from $26.2 million in Q4 2021.
BiomX (PHGE) Long-Term Deferred Tax (2019 - 2022) Analysis & Trends
BiomX has reported Long-Term Deferred Tax for 3 years, with the latest figure at $24.5 million in Q4 2022.
- Quarterly Long-Term Deferred Tax fell 6.48% year-over-year to $24.5 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $24.5 million (down 6.48% YoY) and the FY2022 annual result came in at $24.5 million, down 6.48% from the prior year.
- Long-Term Deferred Tax retreated to $24.5 million in Q4 2022 per PHGE's latest filing, from $26.2 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $26.2 million in Q4 2021 and troughed at $1222.0 in Q2 2019.
- A 3-year average of $16.9 million and a median of $24.5 million in 2022 frame the typical range for Long-Term Deferred Tax.
- The widest YoY moves for Long-Term Deferred Tax: up 6.48% in 2022, down 6.48% in 2022.
- Over 3 years, Long-Term Deferred Tax stood at $1222.0 in 2019, then soared by 2144499.02% to $26.2 million in 2021, then declined by 6.48% to $24.5 million in 2022.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $24.5 million, $26.2 million, and $1222.0 for Q4 2022, Q4 2021, and Q2 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | BiomX | 361,408.40 | -806,591.60 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 24.51 Mn |
| Dec 31, 2021 | 26.21 Mn |
| Jun 30, 2019 | 1,222.00 |